PvP Biologics' Corporate Minority Round

PvP Biologics raised a round of funding on January 05, 2017. Investors include Takeda Pharmaceutical.

PvP Biologics is developing an oral enzyme for the treatment of celiac disease. The company's mission is to develop a highly-effective therapeutic product to reduce the burden of living with this dise…

Articles about PvP Biologics' Corporate Minority Round: